Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,542 | 11,456 | 17,088 | 20,554 | 15,562 |
| TOTAL | $21,215 | $12,466 | $18,119 | $22,391 | $17,121 |
| Non-Current Assets | |||||
| PPE Net | 66 | 70 | 76 | 89 | 91 |
| Investments And Advances | 50 | 50 | 50 | 50 | 50 |
| Other Non-Current Assets | 391 | 391 | 0 | 0 | 0 |
| TOTAL | $507 | $511 | $126 | $138 | $141 |
| Total Assets | $21,721 | $12,977 | $18,245 | $22,529 | $17,262 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,475 | 3,680 | 4,794 | 4,220 | 2,596 |
| Other current liabilities | 54 | 426 | 576 | 301 | 432 |
| TOTAL | $3,529 | $4,106 | $5,370 | $4,521 | $3,028 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,529 | $4,106 | $5,370 | $4,521 | $3,028 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,665 | 2,665 | 1,946 | 1,858 | 1,856 |
| Common Shares | 80 | 59 | 57 | 56 | 48 |
| Retained earnings | -157,990 | -151,667 | -144,613 | -136,552 | -129,856 |
| TOTAL | $18,192 | $8,871 | $12,875 | $18,008 | $14,234 |
| Total Liabilities And Equity | $21,721 | $12,977 | $18,245 | $22,529 | $17,262 |